Neural Mechanisms of Cancer Pain

癌痛的神经机制

基本信息

  • 批准号:
    10412037
  • 负责人:
  • 金额:
    $ 36.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-06-01 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT The management of cancer pain remains a major challenge. Cancer pain is a complex pain state that includes inflammatory, neuropathic components and a unique set of cancer-specific components. Exosomes secreted by cancer cells is one of those cancer-specific factors. In preliminary studies, exosomes confirmed by size and expression of protein markers, induced acute mechanical and heat hyperalgesia following injection into the hind paw of both sexes of naïve C3H/HeN mice. This project will test the hypothesis that exosomes secreted by fibrosarcoma cells produce pain by sensitizing nociceptive primary afferent neurons via the autotaxin (ATX)-lysophosphatidic acid (LPA)-LPA1 receptor (R) pathway. Exosomes isolated from fibrosarcoma cell-conditioned media will be verified by size (Nanoparticle tracking analysis), expression of the exosome-specific markers, and activity of ATX. Electrophysiological studies in vivo will determine the contribution of ATX-LPA-LPA1R signaling to exosome-specific sensitization of nociceptors. At the cellular level, acute sensitization of small dorsal root ganglion (DRG) neurons from adult mice will be defined in a bioassay that measures the occurrence of a calcium transient in response to depolarization with 25 mM KCl in vitro with Indo-1. Whether the exosome-bound ATX-LPA complex released from fibrosarcoma cells sensitizes DRG neurons through activation of LPA1 receptors will be determined using pharmacological and molecular (siRNA) approaches. Resolvin D1 is proposed to attenuate exosome-evoked sensitization of nociceptors and hyperalgesia by interfering with ATX-LPA- LPA1R signaling. If exosome-mediated ATX-LPA-LPA1R signaling underlies hyperalgesia, it will provide insight into a new strategy for managing bone cancer pain. Future studies will further investigate the molecular, biochemical and electrophysiological mechanisms by which exosomes released from cancer cells contribute to cancer pain.
摘要 癌症疼痛的管理仍然是一个重大挑战。癌痛是一种复杂的疼痛 包括炎症,神经病变成分和一组独特的癌症特异性 件.由癌细胞分泌的外泌体是这些癌症特异性因子之一。在 初步研究,通过蛋白质标记物的大小和表达证实的外泌体,诱导 向两种性别动物的后爪注射以下物质后的急性机械和热痛觉过敏: C3 H/HeN小鼠。该项目将测试细胞分泌外泌体的假设 纤维肉瘤细胞通过致敏伤害性初级传入神经元产生疼痛, 自分泌运动因子(ATX)-溶血磷脂酸(LPA)-LPA 1受体(R)途径。分离的外来体 纤维肉瘤细胞条件培养基中的细胞将通过大小进行验证(纳米颗粒跟踪 分析)、外泌体特异性标志物的表达和ATX的活性。电生理 体内研究将确定ATX-LPA-LPA 1 R信号传导对外泌体特异性 伤害感受器的敏感化。在细胞水平上,小背根急性致敏 来自成年小鼠的神经节(DRG)神经元将在生物测定中被定义,该生物测定测量来自成年小鼠的神经节(DRG)神经元中的神经元。 体外25 mM KCl去极化反应中发生钙瞬变 Indo-1纤维肉瘤细胞是否释放了外泌体结合的ATX-LPA复合物 通过激活LPA 1受体使DRG神经元敏感的作用将使用 药理学和分子(siRNA)方法。建议使用Resolvin D1来减弱 外泌体通过干扰ATX-LPA引起的伤害感受器敏化和痛觉过敏 LPA 1 R信号传导。如果外泌体介导的ATX-LPA-LPA 1 R信号转导是痛觉过敏的基础,那么它将 提供了一个新的策略管理骨癌疼痛的见解。未来的研究将进一步 研究分子,生物化学和电生理机制, 从癌细胞释放的外来体有助于癌症疼痛。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Donald Simone其他文献

Donald Simone的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Donald Simone', 18)}}的其他基金

Neural Mechanisms of Cancer Pain
癌痛的神经机制
  • 批准号:
    10171566
  • 财政年份:
    2019
  • 资助金额:
    $ 36.76万
  • 项目类别:
Neural Mechanisms of Cancer Pain
癌痛的神经机制
  • 批准号:
    10627932
  • 财政年份:
    2019
  • 资助金额:
    $ 36.76万
  • 项目类别:
Functional Interactions between Cancer Cells and Sensory Neurons
癌细胞和感觉神经元之间的功能相互作用
  • 批准号:
    8207959
  • 财政年份:
    2010
  • 资助金额:
    $ 36.76万
  • 项目类别:
Functional Interactions between Cancer Cells and Sensory Neurons
癌细胞和感觉神经元之间的功能相互作用
  • 批准号:
    8011521
  • 财政年份:
    2010
  • 资助金额:
    $ 36.76万
  • 项目类别:
Functional Interactions between Cancer Cells and Sensory Neurons
癌细胞和感觉神经元之间的功能相互作用
  • 批准号:
    7762959
  • 财政年份:
    2010
  • 资助金额:
    $ 36.76万
  • 项目类别:
A New Device for Rapid Measurement of Touch Sensation in neuropathy
一种快速测量神经病触觉的新装置
  • 批准号:
    7928750
  • 财政年份:
    2009
  • 资助金额:
    $ 36.76万
  • 项目类别:
Neural Mechanisms of Cancer Pain
癌痛的神经机制
  • 批准号:
    6515035
  • 财政年份:
    2001
  • 资助金额:
    $ 36.76万
  • 项目类别:
Neural Mechanisms of Cancer Pain
癌痛的神经机制
  • 批准号:
    7667445
  • 财政年份:
    2001
  • 资助金额:
    $ 36.76万
  • 项目类别:
Neural Mechanisms of Cancer Pain
癌痛的神经机制
  • 批准号:
    6853614
  • 财政年份:
    2001
  • 资助金额:
    $ 36.76万
  • 项目类别:
Neural Mechanisms of Cancer Pain
癌痛的神经机制
  • 批准号:
    7317584
  • 财政年份:
    2001
  • 资助金额:
    $ 36.76万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 36.76万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.76万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 36.76万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.76万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 36.76万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.76万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 36.76万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 36.76万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 36.76万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.76万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了